nitpicker / Shutterstock.com
30 June 2022Big Pharma
CMA costs case improves access to justice
On May 25, 2022, the UK Supreme Court (UKSC) handed down its judgment ([2022] UKSC 14) in the joint appeals of Pfizer and Flynn (the Appellants) against a costs ruling by the Court of Appeal (the COA Costs Ruling).
